Antibiotic prophylaxis of endocarditis: What is accomplished and at what cost? Donald KayeJerry M. Zuckerman Invited Commentary Pages: 1 - 3
The role of antibiotics in acute exacerbations of chronic obstructive pulmonary disease Sanjay Sethi OriginalPaper Pages: 9 - 15
Therapeutic options for herpes simplex infections Eugene AuStephen L. Sacks OriginalPaper Pages: 22 - 27
The treatment of severe group a streptococcal infections Anna Norrby-TeglundS. Ragnar NorrbyDonald E. Low OriginalPaper Pages: 28 - 37
The development of miltefosine for the treatment of visceral and cutaneous Leishmaniasis Richard D. Pearson Clinical Trials Report Pages: 41 - 42
Special challenges in the prevention and treatment of malaria in children William M. StaufferDeepak Kamat OriginalPaper Pages: 43 - 52
Babesiosis: An update on epidemiology and treatment Jeffrey A. GelfandMichael V. Callahan OriginalPaper Pages: 53 - 58
Changing epidemiology and approaches to therapy for Chagas disease Louis V. Kirchhoff OriginalPaper Pages: 59 - 65
Emerging causes of traveler’s diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia Richard Goodgame OriginalPaper Pages: 66 - 73
HIV-1 fitness and replication capacity: What are they and can they help in patient management? Frank Maldarelli OriginalPaper Pages: 77 - 84
Update on Kaposi’s sarcoma: A gammaherpesvirus-induced malignancy Pallavi P. KumarRichard F. LittleRobert Yarchoan OriginalPaper Pages: 85 - 92